Citi Starts Arsanis Inc. (ASNS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Cowen Starts Arsanis Inc. (ASNS) at Outperform
December 11, 2017 6:14 AM ESTCowen initiates coverage on Arsanis Inc. (NASDAQ: ASNS) with a Outperform rating.
Analyst Ritu Baral sees an excellent chance of success for the ongoing Ph2 of lead drug ASN100 in S. aureus ventilator-associated pneumonia, or VAP (top-line in 2019).
They also believe ASNS'... More
Piper Jaffray Starts Arsanis Inc. (ASNS) at Overweight
December 11, 2017 4:30 AM ESTPiper Jaffray initiates coverage on Arsanis Inc. (NASDAQ: ASNS) with a Overweight rating and a price target of $23.00.
Analyst Ed Tenthoff believes the company has a powerful product in S. Aureus noting is "is a killer in the hospital" and is bullish... More
